Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medline Inc. Class A Common Stock (MDLN) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance

Medline Inc. Class A Common StockTrade
Revolution Medicines Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Medline Inc. Class A Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? Medline Inc. Class A Common Stock trades at $35.67 (market cap $31.36B), while Revolution Medicines Inc. Common Stock trades at $186.54 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is the larger of the two by market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Medline Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medline Inc. Class A Common Stock for 0 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.

MDLNRVMD
Market Cap
$31.36B$40.32B
Volume
10,191,2514,855,734
Sector
HealthHealth
52-Week High
$49.99$221.15
52-Week Low
$31.64$47.50
Typical Hold Time
0 Days0 Days
Enterprise Value
$41.32B$37.02B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MDLN
100% Buy0% Sell
Avg holding period · 0 Days
RVMD
100% Buy0% Sell
Avg holding period · 0 Days

About Medline Inc. Class A Common Stock

Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.

Read more on MDLN →

About Revolution Medicines Inc. Common Stock

Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.

Read more on RVMD →